IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Pharmaceutical
Sub Sector: Manufacturing and export of both pharmaceutical formulations and nutraceutical products
Exchange:
BSE
Emerge
Asston Pharmaceuticals is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African markets. The Company operates under brand “Asston”. Presently, their Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion) and Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, their Company also manufactures various pharmaceutical products for different marketers on loan license or on contract manufacturing basis. Their business is primarily conducted on a principle-to-principle basis with various marketers. As on the date, they cater to multiple corporate clients on loan licence and/or contract manufacturing basis. Currently, their Company has its production facility at Ambernath, Maharashtra, for producing generic medicines in the tablet form and nutraceutical medicines in the tablet form, syrup and sachet form. They have a dedicated and separate floors for pharmaceutical products and nutraceutical products respectively as the norms and standards are different for both of them and are governed by FDA and FSSAI respectively. Since the FDA norms for pharmaceutical products are much more stringent, to comply with FDA standards separate guidelines are there to be followed. Facility has total production capacity of up to around 8-9 crore tablets per month. The Company produces an average of 5-6 crore tablets per month, with production capacity varying based on the weight of the medicines. Higherweight medicines result in lower production quantities and vice versa. The syrup production capacity for nutraceuticals is approximately 37.5 kiloliters per month, while sachet production capacity ranges from 30 to 40 lakh sachets per month, depending on the powder weight per sachet.
Maashitla Securities Private Limited
Asston Pharmaceuticals operates in Pharmaceutical and Manufacturing and export of both pharmaceutical formulations and nutraceutical products. The Issue would be listed on SME. The registrar of the Issue is Maashitla Securities Private Limited. The IPO type of Asston Pharmaceuticals is Book Building Process and Object of issue is
Merchant Banker of Asston Pharmaceuticals IPO is Sobhagya Capital Options Limited
The DRHP (Draft Red Herring Prospectus) of Asston Pharmaceuticals IPO was filed on 16 Jan 2025.
No, Asston Pharmaceuticals IPO is not yet listed. See other upcoming SME IPOs here.
The IPO open date and IPO close date of Asston Pharmaceuticals are not available now. You can apply in Asston Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application can be done through net banking of your bank account. UPI IPO application is also offered by brokers, though they don't handle any banking services.
Why Us?
